Damon Pierce, MD
Vascular Surgery · Seattle, WANPI 1912101742
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Cardiovascular Systems Inc. accounts for 61.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2020 at $5,075 and has fallen 91.2% since, to $447 in 2025.
Across 37 payments — averaging $217.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardiovascular Systems Inc.$5K
- W. L. Gore & Associates, Inc.$2K
- Medtronic$190
- Terumo Medical Corporation$159
- Cook Medical LLC$76
- Biom'up France SAS$74
- plus $76 from 3 others
Across 2 payments — averaging $4956.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Silk Road Medical, Inc.$10K
What the payments were for
- Consulting fees$1502%
- Speaking & faculty fees$4,80060%
- Travel & lodging$1,40617%
- Food & beverage$1,68521%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cardiovascular Systems Inc. | 5 | $4,969 |
| W. L. Gore & Associates, Inc. | 18 | $2,496 |
| Medtronic(2 entities) | 5 | $190 |
| Terumo Medical Corporation | 1 | $159 |
| Cook Medical LLC | 2 | $76 |
| Biom'up France SAS | 2 | $74 |
| Organogenesis Inc. | 2 | $40 |
| Johnson & Johnson | 1 | $27 |
| Venclose Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Peripheral Orbital Atherectomy System$4,950
- GORE TAG Thoracic Endoprosthesis$1,239
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$333
- EXCLUDER AAA Endoprosthesis$248
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$239
- PROGREAT$159
- Azur CX Detachable$159
- Avalus$130
- GORE EXCLUDER AAA Endoprosthesis$124
How this compares
$8,041 in reported general payments places this provider in the 65th percentile of 111 vascular surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular surgery in Seattle
- Sara ZettervallSeattle$126K
- Paul HayesSeattle$83K
- Elina QuirogaSeattle$69K
- Mark MeissnerSeattle$43K
- Niten SinghSeattle$33K
- Matthew SweetSeattle$28K
- Matthew BennettSeattle$23K
- Saideep BoseSeattle$18K
- Jake HemingwaySeattle$15K
- Jose TraniSeattle$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.